Industry Insights Logo

Referral Documentation Defensibility

SPONSORED CONTENT

Covered entities participating in the 340B program continue to operate in an environment of increasing complexity and scrutiny. As regulatory expectations evolve, one area that has emerged as a critical point of vulnerability is referral

Read More »
Industry Insights Logo

Top HRSA Audit Findings in FY2025

SPONSORED CONTENT

In fiscal year 2025, the Health Resources and Services Administration (HRSA) audited 115 covered entities — and 49% received adverse findings. In other words, nearly one in two programs had a 340B compliance issue last year.

While this

Read More »

RxParadigm

Q: Tell us some interesting details about your company’s history.

At RxParadigm, we like to think we’ve always been a few steps ahead, not because we have a crystal

Read More »
Industry Insights Logo

Readiness Over Reaction

SPONSORED CONTENT

Uncertainty has become a constant in the 340B landscape. Legal challenges, shifting manufacturer policies, and evolving oversight have made one thing clear: waiting for definitive answers before taking action is no longer a viable strategy.


For covered

Read More »
340B Solutions Spotlight

Q: What is the primary problem 340B Referral Compass solves?

Referral Compass helps covered entities (CEs) address one of the most difficult and often underdeveloped areas…

Read More »
Industry Insights Logo

Your 340B Performance Is Already Changing Under the IRA

SPONSORED CONTENT

There has been no formal announcement explaining how the Inflation Reduction Act (IRA) is playing out operationally within 340B.

Instead, it’s showing up in the data. For many organizations, it looks subtle at first. A dip in qualified claims.

Read More »
Industry Insights Logo

The IRA Just Rewrote the 340B Playbook. Most Programs Haven’t Caught Up.

SPONSORED CONTENT

Q1 2026 started rougher than predicted for 340B programs. Ceiling prices compressed. Penny pricing disappeared on drugs that used to be your biggest savings. And an entire drug category that looked like a growth engine 12 months ago went

Read More »

Q: What is the primary problem Pillr One solves?

340B programs are increasingly difficult to manage across fragmented systems that handle mixed-use, central distribution, contract…

Read More »

340B INDUSTRY LEADER SPOTLIGHT

Heather Brooks, VP of Pharmacy Services Product, VytlOne

Heather Brooks

Q: Where did you grow up?

South Alabama

Q: Tell us about your educational background and training.

I graduated from Auburn University’s Harrison School of Pharmacy. My career as a pharmacist includes retail, hospital, and specialty pharmacy.

Q: What are your favorites?

Food: Mexican, chocolate

Movie: I do not watch many movies, but

Read More »
Expert Tip

Expert Tip from Proximity

img

TIP: Regularly review your 340B ESP configuration to ensure alignment across TPA & wholesaler systems, because even small inconsistencies can quietly escalate into significant missed savings opportunities.

Read More »

Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Site Footer Live